Edgen Stock·Oct 31 2025, 21:45Back
Corbus Pharmaceuticals Adjusts CRB-701 Strategy Amid Competitive Landscape, Shares Decline Post-Offering
Edgen Stock·Oct 31 2025, 21:45
[1] Corbus Pharmaceuticals: Downgrade To Hold Due To Narrow Focus Window (NASDAQ:CRBP) (https://seekingalpha.com/article/4836558-corb ...)[2] Corbus Pharmaceuticals: Downgrade To Hold Due To Narrow Focus Window (https://vertexaisearch.cloud.google.com/groun ...)[3] Corbus Pharmaceuticals Presents CRB-701 Robust Clinical Responses in HNSCC and Cervical Cancers at ESMO25 - Stock Titan (https://vertexaisearch.cloud.google.com/groun ...)
